146 related articles for article (PubMed ID: 1556456)
1. [Progress on diagnosis and therapy of kidney diseases complicated with systemic scleroderma and dermatomyositis].
Kondo H
Nihon Naika Gakkai Zasshi; 1992 Jan; 81(1):18-21. PubMed ID: 1556456
[No Abstract] [Full Text] [Related]
2. [Scleroderma renal crisis (SRC): hypertensive, normotensive].
Endo H
Nihon Rinsho Meneki Gakkai Kaishi; 2000 Dec; 23(6):656-60. PubMed ID: 11210764
[No Abstract] [Full Text] [Related]
3. [Treatment of nephropathy in patients with periarteritis nodosa, systemic scleroderma and dermatomyositis].
Siniachenko VV
Klin Med (Mosk); 1971 May; 49(5):118-22. PubMed ID: 4400915
[No Abstract] [Full Text] [Related]
4. Reversal of vascular and renal crises of scleroderma by oral angiotensin-converting-enzyme blockade.
Lopez-Ovejero JA; Saal SD; D'Angelo WA; Cheigh JS; Stenzel KH; Laragh JH
N Engl J Med; 1979 Jun; 300(25):1417-9. PubMed ID: 220537
[No Abstract] [Full Text] [Related]
5. ACE inhibitors for scleroderma renal crisis.
Ann Intern Med; 1991 Feb; 114(3):249-50. PubMed ID: 1984753
[No Abstract] [Full Text] [Related]
6. [Kidney in collagen diseases].
Klinger M
Pol Tyg Lek; 1981 Jul; 36(27):1027-30. PubMed ID: 6117844
[No Abstract] [Full Text] [Related]
7. [Scleroderma and dermatomyositis].
Kondo H; Endo H
Nihon Naika Gakkai Zasshi; 2005 May; 94(5):876-80. PubMed ID: 15926454
[No Abstract] [Full Text] [Related]
8. [Sclerodermic kidney].
Guseva NG; Gritsman NN; Alekberova ZS; Akhnazarova VD; Balabanova RM
Ter Arkh; 1981; 53(11):40-5. PubMed ID: 7339905
[No Abstract] [Full Text] [Related]
9. The kidney in progressive systemic sclerosis (scleroderma).
Dichoso CC
Perspect Nephrol Hypertens; 1976; 3():57-74. PubMed ID: 765954
[No Abstract] [Full Text] [Related]
10. Captopril hepatotoxicity in a case of renal crisis due to systemic sclerosis.
Deira JL; Corbacho L; Bondía A; Lerma JL; Gascón A; Martín B; García P; Tabernero JM
Nephrol Dial Transplant; 1997 Aug; 12(8):1717-8. PubMed ID: 9269658
[No Abstract] [Full Text] [Related]
11. Renal manifestations of systemic sclerosis--clinical features and outcome assessment.
Denton CP
Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v54-6. PubMed ID: 18784147
[TBL] [Abstract][Full Text] [Related]
12. [Kidney involvement in progressive scleroderma].
Blumenstein M; Sorodoc J; Weiss M
Dtsch Med Wochenschr; 1997 Feb; 122(7):200-4. PubMed ID: 9072491
[No Abstract] [Full Text] [Related]
13. Use of angiotensin-converting-enzyme inhibitors in the management of renal disease.
Asher JP; Murray KM
Clin Pharm; 1991 Jan; 10(1):25-31. PubMed ID: 1999085
[TBL] [Abstract][Full Text] [Related]
14. The scleroderma kidney: progress in risk factors, therapy, and prevention.
Bussone G; Bérezné A; Pestre V; Guillevin L; Mouthon L
Curr Rheumatol Rep; 2011 Feb; 13(1):37-43. PubMed ID: 21061100
[TBL] [Abstract][Full Text] [Related]
15. [Case of a prolonged course of systemic scleroderma with elements of dermatomyositis].
Mozhaĭtseva AG; Soboleva MS
Sov Med; 1970 Sep; 33(9):146-7. PubMed ID: 5494164
[No Abstract] [Full Text] [Related]
16. [Biochemical diagnosis of kidney diseases in systemic scleroderma].
Balabanova RM; Kaĭnova AS; Stepanova NS
Ter Arkh; 1979; 51(3):64-7. PubMed ID: 441956
[No Abstract] [Full Text] [Related]
17. Carpal tunnel syndrome in dermatomyositis and scleroderma.
Quinones CA; Perry HO; Rushton JG
Arch Dermatol; 1966 Jul; 94(1):20-5. PubMed ID: 5938219
[No Abstract] [Full Text] [Related]
18. The kidneys in systemic lupus erythematosus and other collagen diseases: recent progress.
Pirani CL; Silva FG
Monogr Pathol; 1979; 20():98-139. PubMed ID: 41179
[No Abstract] [Full Text] [Related]
19. [Renal involvement in scleroderma].
Boffa JJ; Rossert J
Rev Prat; 2002 Nov; 52(17):1910-4. PubMed ID: 12532868
[TBL] [Abstract][Full Text] [Related]
20. [Clinicopathological studies of SLE, scleroderma and dermatomyositis associated with vasculitis].
Ofuji T
Nihon Rinsho; 1978 Apr; 36(4):747-52. PubMed ID: 671750
[No Abstract] [Full Text] [Related]
[Next] [New Search]
